McKesson Corporation  

(Public, NYSE:MCK)   Watch this stock  
Find more results for MCK
194.56
+1.12 (0.58%)
Jul 29 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 191.20 - 195.13
52 week 148.29 - 224.73
Open 192.79
Vol / Avg. 1.44M/1.30M
Mkt cap 43.14B
P/E 19.06
Div/yield 0.28/0.58
EPS 10.21
Shares 225.70M
Beta 0.92
Inst. own 87%
Oct 27, 2016
Q2 2017 McKesson Corp Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jul 28, 2016
McKesson Corp Annual Shareholders Meeting (Estimated)
Jul 27, 2016
Q1 2017 McKesson Corp Earnings Call - Webcast
Jul 27, 2016
Q1 2017 McKesson Corp Earnings Release
Jul 27, 2016
McKesson Corp Annual Shareholders Meeting
Jun 29, 2016
McKesson Corp Investor Day - Webcast
Jun 28, 2016
McKesson Corp and Change Healthcare Holdings Inc Conference call to Discuss the Creation of a New Healthcare Information Technology Company
May 11, 2016
McKesson Corp at Bank of America Merrill Lynch Health Care Conference
May 4, 2016
Q4 2016 McKesson Corp Earnings Call
May 4, 2016
Q4 2016 McKesson Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '16) 2016
Net profit margin 1.35% 1.23%
Operating margin 1.95% 1.86%
EBITD margin - 2.43%
Return on average assets 4.72% 4.24%
Return on average equity 28.91% 27.06%
Employees 68,000 -
CDP Score - -

Address

1 Post St
SAN FRANCISCO, CA 94104-5203
United States - Map
+1-415-9838300 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology.

Officers and directors

John Harvey Hammergren Chairman of the Board, President, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
James A. Beer Chief Financial Officer, Executive Vice President
Age: 54
Bio & Compensation  - Reuters
Kathleen D. McElligott Executive Vice President, Chief Technology Officer, Chief Information Officer
Age: 59
Bio & Compensation  - Reuters
Lori Ann Schechter Executive Vice President, Chief Compliance Officer, General Counsel
Age: 53
Bio & Compensation  - Reuters
Jorge L. Figueredo Executive Vice President - Human Resources
Age: 54
Bio & Compensation  - Reuters
Patrick J. Blake Executive Vice President, Group President
Age: 51
Bio & Compensation  - Reuters
Paul Coleman Julian Executive Vice President, Group President
Age: 61
Bio & Compensation  - Reuters
Bansi Nagji Executive Vice President - Corporate Strategy and Business Development
Age: 50
Bio & Compensation  - Reuters
Edward A. Mueller Lead Director
Age: 68
Bio & Compensation  - Reuters
Andrew D. Bryant Independent Director
Age: 65
Bio & Compensation  - Reuters